A drug interaction between fusidic acid and a combination of ritonavir and saquinavir

被引：0
|
作者：
Khaliq, Y
Gallicano, K
Leger, R
Foster, B
Badley, A
机构：
[1] Ottawa Gen Hosp, Clin Invest Unit, Ottawa, ON K1H 8L6, Canada
[2] Ottawa Gen Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada
[3] Univ Ottawa, Ottawa, ON, Canada
[4] Hlth Canada, Specialisees Med Familiale, Ottawa, ON K1A 0L2, Canada
[5] Hlth Canada, Therapeut Prod Programme, Ottawa, ON K1A 0L2, Canada
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2000年 / 50卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：82 / 83
页数：2
相关论文
共 50 条
  • [31] The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir
    la Porte, C. J. L.
    Li, Y.
    Beique, L.
    Foster, B. C.
    Chauhan, B.
    Garber, G. E.
    Cameron, D. W.
    van Heeswijk, R. P. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (04) : 389 - 395
  • [32] Fusidic-acid/itraconazole/rifampicinCardiotoxicity and drug-drug pharmacokinetic interaction: case report
    Reactions Weekly, 2025, 2055 (1) : 155 - 155
  • [33] Drug interaction between amprenavir and lopinavir/ritonavir in salvage therapy
    Khanlou, H
    Graham, E
    Brill, M
    Farthing, C
    AIDS, 2002, 16 (05) : 797 - 798
  • [34] Unexpected drug-drug interaction between amprenavir (APV) and ritonavir (RTV)
    Poirier, J. M.
    Meynard, J. L.
    Guiard-Schmid, J. B.
    Morand-Joubert, L.
    Schneider, V.
    Jacquemet, N.
    Girard, P. M.
    Rozenbaum, W.
    Jaillon, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 65 - 65
  • [35] Drug-Drug Interaction Between Itraconazole and the Protease Inhibitor Lopinavir/Ritonavir
    Hills-Nieminen, Cara
    Hughes, Christine A.
    Houston, Stan
    Shafran, Stephen D.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (12) : 2117 - 2120
  • [36] Coionic-hydrophobic interaction between fusidic acid and carboxylic biosorbents
    Samsonov, GV
    Pisarev, OA
    Suchkova, GS
    Murav'eva, TD
    Bernotaitite, MV
    Komogorova, TA
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 1998, 34 (03) : 220 - 221
  • [37] Fusidic acid adverse drug reactions
    Christiansen, K
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 : S3 - S9
  • [38] Presumed interaction of fusidic acid with simvastatin
    Burtenshaw, A. J.
    Sellors, G.
    Downing, R.
    ANAESTHESIA, 2008, 63 (06) : 656 - 658
  • [39] Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir
    Valer, L
    Mendoza, CC
    de Requena, DG
    Labarga, P
    García-Henarejos, A
    Barreiro, P
    Guerrero, F
    Vergara, A
    Soriano, V
    AIDS, 2002, 16 (14) : 1964 - 1966
  • [40] Rate of onset of hyperlipidaemia following treatment with ritonavir/saquinavir and correlation with drug levels
    Churchill, DR
    Pym, AS
    Babiker, AG
    Back, DJ
    Weber, JN
    AIDS, 1998, 12 : S9 - S9
12345